Michael A Staszak

age ~69

from Boulder, CO

Get Report

Also known as:

Connected to:

Michael Staszak Phones & Addresses

view source

Location:

United States

Pharmaceutical Compounds
view source
US Patent:

6395735, May 28, 2002
Filed:

Dec 19, 2000
Appl. No.:

09/740380
Inventors:

Sean Patrick Hollinshead - Durham NC
Philip Floyd Hughes - Chapel Hill NC
Jose Serafin Mendoza - Durham NC
Joseph Wendell Wilson - Durham NC
Bret Eugene Huff - Mooresville IN
Charles Howard Mitch - Columbus IN
Michael Alexander Staszak - Indianapolis IN
John Stanley Ward - Indianapolis IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

A61K 31155
US Classification:

5142378, 514331, 514428, 514637, 544159, 544165, 546234, 548569, 564245
Abstract:

The present invention provides novel indane-like compounds which can be useful for treating psychosis and other conditions associated with the modulation of a muscarinic receptor. The invention provides formulations and methods for using the novel compounds.

Indane Derivatives For Antipsychotic Compositions
view source
US Patent:

6429317, Aug 6, 2002
Filed:

Sep 5, 2000
Appl. No.:

09/117089
Inventors:

Sean P. Hollinshead - Durham NC
Michael A. Staszak - Indianapolis IN
John S. Ward - Indianapolis IN
Joseph W. Wilson - Durham NC
Bret E. Huff - Mooresville IN
Philip F. Hughes - Chapel Hill NC
Jose S. Mendoza - Durham NC
Charles H. Mitch - Columbus IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

C07D20708
US Classification:

548566, 546162, 546206, 546281, 546314, 546315, 546316, 548567, 548568, 549 57, 549 72, 564 80, 564 92, 564 93, 564162, 514319, 514343, 514353, 514355, 514428, 514438, 514443, 514444, 514448, 514522, 514523, 514524, 514604
Abstract:

The present invention provides novel indane-like compounds which can be useful for treating psychosis and other conditions associated with the modulation of a muscarinic receptor. The invention provides formulations and methods for using the novel compounds.

Preparation Of Substituted Piperidin-4-Ones
view source
US Patent:

6538136, Mar 25, 2003
Filed:

Dec 11, 2001
Appl. No.:

10/018036
Inventors:

John Robert Rizzo - Indianapolis IN
Michael Alexander Staszak - Indianapolis IN
Tony Yantao Zhang - Indianapolis IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

C07D21140
US Classification:

546192, 546216, 546219
Abstract:

The present invention provides a novel process for the preparation of substituted piperidine-4-ones useful as intermediates in the preparation of pharmaceuticals.

Bis-Piperidinyl Non-Peptidyl Neurokinin Receptor Antagonists
view source
US Patent:

55300090, Jun 25, 1996
Filed:

Jun 5, 1996
Appl. No.:

8/462413
Inventors:

Sung Yong S. Cho - Indianapolis IN
James D. Copp - Greenwood IN
Francis O. Ginah - Indianapolis IN
Guy J. Hansen - Indianapolis IN
Philip A. Hipskind - New Palestine IN
Bret E. Huff - Mooresville IN
Michael J. Martinelli - Indianapolis IN
Michael A. Staszak - Indianapolis IN
Roger W. Tharp-Taylor - Noblesville IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

A61K 31445
C07D40114
US Classification:

514316
Abstract:

This invention provides novel compound of the formula ##STR1## which is neurokinin receptor antagonist.

Glycopeptide Antibiotic Derivatives
view source
US Patent:

58438890, Dec 1, 1998
Filed:

Mar 12, 1997
Appl. No.:

8/816224
Inventors:

Robin D. G. Cooper - Indianapolis IN
Bret E. Huff - Mooresville IN
Thalia I. Nicas - Indianapolis IN
John T. Quatroche - Indianapolis IN
Michael J. Rodriguez - Indianapolis IN
Nancy J. Snyder - Charlottesville IN
Michael A. Staszak - Indianapolis IN
Richard C. Thompson - Frankfort IN
Stephen C. Wilkie - Indianapolis IN
Mark J. Zweifel - Indianapolis IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

C07K 750
C07K 900
A61K 3702
US Classification:

514 8
Abstract:

The present invention provides glycopeptide antibiotic derivative compounds. These derivative compounds possess antibacterial activity aginst a wide variety of bacteria, including activity against vancomycin-resistant isolates. Methods of making and using these glycopeptide antibiotic derivative compounds are also provided.

Glycopeptide Antibiotic Derivatives
view source
US Patent:

58406840, Nov 24, 1998
Filed:

Mar 24, 1995
Appl. No.:

8/410155
Inventors:

Robin D. G. Cooper - Indianapolis IN
Bret E. Huff - Mooresville IN
Thalia I. Nicas - Indianapolis IN
John T. Quatroche - Indianapolis IN
Michael J. Rodriguez - Indianapolis IN
Nancy J. Snyder - Charlottesville IN
Michael A. Staszak - Indianapolis IN
Richard C. Thompson - Frankfort IN
Stephen C. Wilkie - Indianapolis IN
Mark J. Zweifel - Indianapolis IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

A61K 3812
A61K 3814
C07K 754
C07K 900
US Classification:

514 11
Abstract:

The present invention provides glycopeptide antibiotic derivative compounds. These derivative compounds possess antibacterial activity against a wide variety of bacteria, including activity against vancomycin-resistant isolates. Methods of making and using these glycopeptide antibiotic derivative compounds are also provided.

Process For Preparing Indane-Like Compounds
view source
US Patent:

6211364, Apr 3, 2001
Filed:

Jun 10, 1999
Appl. No.:

9/319652
Inventors:

Bret E Huff - Zionsville IN
Michael A Staszak - Indianapolis IN
John S Ward - Indianapolis IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

C07D26530
C07D21106
C07D20704
C07C23300
C07C21100
US Classification:

544106
Abstract:

The present invention provides intermediate for the preparation of indane-like compounds which are useful for the modulation of a muscarinic receptor.

Process Of Enantiomeric Separation Of Carbacephem Intermediates
view source
US Patent:

51420384, Aug 25, 1992
Filed:

Jul 23, 1991
Appl. No.:

7/734394
Inventors:

Christopher W. Doecke - Greenwood IN
Jeffrey N. Levy - Lafayette IN
Wayne D. Luke - West Lafayette IN
Michael A. Staszak - Indianapolis IN
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

C07D205085
C07B 5700
US Classification:

540200
Abstract:

Enantiomerically pure. beta. -lactam intermediates of the formula (I) ##STR1## are isolated from a haloalkane solvent through precipitation with methyl-t-butyl ether or methanol. The products thus obtained are key intermediates in the synthesis of antibiotic aagents. The process is appropriate for large scale production.